Positive trials of bladder cancer treatment

Israel’s Biocancell Therapeutics has reported a successful clinical trial on high-risk bladder cancer patients.  It will allow the company to proceed to a Phase III trial of its BC-819 product, which is administered together with BCG, the standard treatment.


This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.